Sharpens Focus on Innovative ADAPTIR® Bispecific Antibody Platform and IXINITY® Commercial Asset Strengthens Cash Position ...
Oslo, Norway, 3 May 2018 - Targovax ASA (OSE: TRVX), a clinical stage company ...
Dublin, June 21, 2018 (GLOBE NEWSWIRE) -- The "Global Point-of-Care Testing Market, by Product ...
